In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malcolm Spicer

Malcolm Spicer, Managing Editor – US

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.

Latest From Malcolm Spicer

In $4.4 Trillion ‘Global Wellness Economy’ Of 2020, Supplement Sales Accounted For $137.7 Billion

Global Wellness Institute’s vitamins and supplements, healthy-labeled foods and beverages and weight loss products and services overall showed 3.6% sales growth to $945bn from 2019 to 2020, according to institute’s latest report.

Dietary Supplements Market Intelligence

Change At P&G Helm But Not In Course

Speaking at conferences or in P&G’s earnings briefings wasn’t part of previous CEO David Taylor’s strategy. But Jon Moeller has been a mainstay of P&G presentations for years and likely will continue the role.

Executive Changes Consumer

Groomed For Sustainable Growth, P&G Positions Shaving Brands To Provide Marketplace Edge

In first presentation at P&G’s helm, Jon Moeller says firm was groomed under his predecessor to grow revenues and income by developing line extensions for daily-use products offered at premium prices and by simplifying its operations for efficiency from executive suites to local distribution channels.

Business Strategies Executive Changes

NAC’s Longevity In US Dietary Supplement Market Swings On Comments As NDI Notifications

FDA ODSP details “data, research results, and other information” it needs on NAC that could sway proposing a rulemaking to allow its continued use in supplements. One detail missing is what the agency’s asking for are NDI notifications for NAC.

Dietary Supplements FDA

P&G Among US Firms Asked To Explain How, Why Supply Chain Problems Cause Consumer Hardships

Procter & Gamble and Amazon are among nine companies FTC ordered to provide detailed information to help the agency identify causes behind ongoing supply chain disruptions. Chairwoman Khan says the information should “shed light on market conditions and business practices that may have worsened these disruptions.”

Coronavirus COVID-19 Consumer

Window Of Opportunity Opened Narrowly For Continued Use Of NAC As Dietary Ingredient In US

FDA will “determine if rulemaking to make NAC lawful as a dietary supplement is appropriate.” Agency issued tentative responses to Council for Responsible Nutrition and Natural Products Association’s petitions asking for halt to warnings and other enforcement against firms marketing supplements containing NAC.

Dietary Supplements FDA
See All
UsernamePublicRestriction

Register